Cellosaurus UG5LN GAL4-hMR (CVCL_E7IU)
| Cell line name | UG5LN GAL4-hMR |
|---|---|
| Accession | CVCL_E7IU |
| Resource Identification Initiative | To cite this cell line use: UG5LN GAL4-hMR (RRID:CVCL_E7IU) |
| Comments | Population: Caucasian. Characteristics: Transfected with a (GAL4RE)5-betaGlobin-Luc-SV40-Neo construct where expression of the luciferase gene is driven by a pentamer of yeast activator GAL4-binding sites in front of beta-globin promoter and a pSG5-GAL4-hMR-puroR construct containing the GAL4 DNA-binding domain fused to the ligand-binding domain of human NR3C2/MR (Inserm Transfert=RT00626). Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7979; NR3C2 (Note=Ligand-binding domain). Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Firefly luciferase. Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; S.alboniger pac (PuroR). Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo. Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain). Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. |
| Sequence variations |
|
| Disease | Osteosarcoma (NCIt: C9145) Osteosarcoma (ORDO: Orphanet_668) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_E7IT (UG5LN) |
| Sex of cell | Female |
| Age at sampling | 15Y |
| Category | Cancer cell line |
| Web pages | Provider; Inserm Transfert; RT00626; https://technology-offers.inserm-transfert.com/offer/ug5ln-gal4-hmr-cell-line/ |
| Entry history | |
| Entry creation | 10-Apr-2025 |
| Last entry update | 10-Apr-2025 |
| Version number | 1 |